Physician profile
Harry E Hicklin
NPI 1992717763
$764.91
in general payments reported to CMS, 2019-2025
13 companies · $40.37 in 2025
The $40.37 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $181 · 2020: $91.61 · 2021: $67.21 · 2022: $11.83 · 2023: $69.99 · 2024: $302 · 2025: $40.37.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $375 · Education: $37.48.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $375.30 |
| Education | $37.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $215.98 | 2019-2021 | |
| Angiodynamics, INC. | $197.71 | 2024 | Angiovac |
| Boehringer Ingelheim Pharmaceuticals, INC. | $129.90 | 2019-2025 | Jardiance |
| Amgen INC. | $72.38 | 2020-2024 | Repatha |
| Irhythm Technologies, INC. | $30.55 | 2024 | Zio Monitor, Zio Xt Patch |
| Pfizer INC. | $20.79 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $20.22 | 2025 | |
| Vifor Pharma, INC. | $13.96 | 2019 | |
| Astellas Pharma US INC | $13.84 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $13.47 | 2021 | |
| Amarin Pharma, INC. | $12.85 | 2019 | |
| Sanofi-Aventis U.S. LLC | $12.18 | 2019 | |
| Janssen Pharmaceuticals, INC | $11.08 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Harry Hicklin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.